Parsabiv ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

parsabiv

amgen europe b.v. - etalcalcetid hidroklorid - hyperparathyroidism, secondary - anti-parathyroid agents, calcium homeostasis - parsabiv je indiciran za liječenje sekundarni hiperparatireoidizam (shpt) u odraslih bolesnika s kroničnim bubrežnim zatajenjem (ckd) na hemodijalizi terapija.

Rienso ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

rienso

takeda pharma a/s - Ферумокситол - anemia; kidney failure, chronic - ostali lijekovi противоанемические - rienso je indiciran za intravensku terapiju željeza-anemija u odraslih bolesnika s kroničnim bubrežnim zatajenjem (ckd). dijagnoze nedostatka željeza mora se temeljiti na odgovarajućim laboratorijskim testovima (vidi odjeljak 4.

Val 160 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

val 160 mg filmom obložene tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - valsartan - filmom obložena tableta - 160 mg - urbroj: jedna filmom obložena tableta sadrži 160 mg valsartana

Val 80 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

val 80 mg filmom obložene tablete

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - valsartan - filmom obložena tableta - 80 mg - urbroj: jedna filmom obložena tableta sadrži 80 mg valsartana

Veklury ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.